Methods The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. endobj Intravenous therapy • For intravenous chemotherapy, patency of the IV access must be confirmed prior to initiating chemotherapy administration. ���=_\t��9�:����g&���*0���MW_C6�)q�Kz!�Z����TU����n��LBK2�WA�hԸzx�.���A7�g�EvDzy`bmi��z�j�j|P���$�y�H���U�HaB�M'��l�%�2,��=�k%SJ��Ve^$߷R-� endstream endobj startxref A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. endobj • The chemotherapy should be checked against the prescription (either electronic or hand written). endobj A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. CC 05 -055 Safe Handling of 47 0 obj <> endobj %PDF-1.7 Depending on treatment complexity, ONS’s Chemotherapy and Biotherapy Guidelines and Recommendations for Practice state that chemotherapy agents being administered by infusion “may be connected directly to … 2 0 obj All dosage and administration rate-related calculations should be independently verified (White … • If using central lines patency must be established by aspirating blood prior … Cancer Chemotherapy Policies p. 6 Tool #4: Self-Assessment Tool and Learning Plan p. 8 Tool #5: Power Point Presentation: Introduction to the CANO\ACIO Standards and Competencies for Cancer Chemotherapy Nursing Practice p. 18 References p. 19 Appendix A p. 21 Appendix B p. 23 Appendix C p. 24 Appendix D p. 28 . Systemic Therapy Policies SOURCE: Chemotherapy Protocols ( ) Page printed: . NATIONAL STRATEGy FOR CHEMOTHERAPy ADMINISTRATION (NSCA) 4 … Chemotherapy, immunotherapy, and hormonal agents are covered when medically indicated and used according to FDA approved indications or as a part of an anticancer chemotherapeutic regimen or cancer treatment regimen. x��}[s7��#��Q<1j 1. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology … Of the utmost importance is that the administration setup ensures chemotherapy is given safely and allows for prompt nursing intervention in the event of an adverse reaction or infiltration. The text also contains guidelines for administration via peripheral or central access and provides vesicant administration considerations. %���� 2.1 The healthcare setting has a policy documenting a standardized process for obtaining and documenting chemotherapy consent or assent (Replaces 6) 2.2 Informed consent or assent for chemotherapy treatment, as appropriate to the treatment population, is documented prior to initiation of a chemotherapy regimen. 78 0 obj <>/Filter/FlateDecode/ID[<4863558DB357C70527577D0E0B66B30F><17AE6FACE83DE444A490CC657B8E0A08>]/Index[47 51]/Info 46 0 R/Length 135/Prev 178740/Root 48 0 R/Size 98/Type/XRef/W[1 3 1]>>stream <> Administration of Cancer Chemotherapy is a high -risk activity requiring additional knowledge and skill. 97 0 obj <>stream endstream endobj 48 0 obj <> endobj 49 0 obj <> endobj 50 0 obj <>stream uu8AQ��eyl��n���lI}�ɦ�M�4��o\d&n�@���(�.�/ Գ��n�~���~��r��/>.�����W?.������ŋ�Wų~k��_���_�E9+��(eS��*��*�˯��_�Q�~��h�Y[�Z�l��.�Z�/n���٫���eS��'RH��2B��[��{Q����a$*���fm�龽�>��?�6��e���_��Iq����~��w��$n��j�rV�N��(�{������nsÏ����Ύ�t���ЎT�U=+���g�S ��o���uaT/\. 4 0 obj Standardized courses and curricula for chemotherapy administration should be developed at each tertiary institution. Portions of this policy may only be performed by Registered Nurses with the post-entry level certification in the Administration of Cancer Chemotherapy . `,�b&���G`�� ������ h�ėmo�HǿʼLTQ��T!HRN��R �-qGJ���xB�%!I��]�ggfg����8B*p��H���-8Vsp�A�y��ށs�����x�ĵ��$�y� ^�d��+�8 ^�T[�(_�$�|��U: t�6��o�vr|W�ʴ��Ny�'��ı�S�8�]A9Ʈ��bWQF��)��5?��,�� ���w��]���,����?Ä��L��_(0��j0��0��Z0��:02�i�GI��=J�a <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 12 0 R 13 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 41 0 R 44 0 R 46 0 R 47 0 R 48 0 R 57 0 R 58 0 R 60 0 R 61 0 R 62 0 R 63 0 R 65 0 R 66 0 R 67 0 R 69 0 R 70 0 R 71 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> Administration Of Intravesical Chemotherapy • Policy • Best Practice Procedure Administration Of Oral Or Topical Cancer Chemotherapy Agents (Including Nasogastric Administration) • Policy • Best Practice Procedure Administration Of Cancer Chemotherapy On Non-Oncology Units • Policy 14 16 26 30 35 39 Definitions 40 Appendices %%EOF The chemotherapy, targeted therapy and related medications must be checked at the point of administration by two registered nurses with the appropriate training and skills. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology Nurses … Table 7 in Chemotherapy and Biotherapy Guidelines and Recommendations for Practice discusses special features required for administration, but package inserts should be referred to for the most up-to-date information. Policies & Procedures: Chemotherapy Drugs for Cancer Treatment: Administration & Precautions I.D. 3 0 obj FE�Y�g+��*O50�O�� ���� ��Ǩ���|������L�$�4#w��N>�Q � �`p Although relevant guidelines and policy statements existed (e.g., OSHA's Controlling Occupational Exposure to Hazardous Drugs, Chapter 2: Safe Handling of Chemotherapy Drugs, the ONS Chemotherapy and Biotherapy Guidelines and Recommendations for Practice, ASCO's Criteria for Facilities and Personnel for the Admi… The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. h�bbd```b``��� �q�d="9��E4��,�dW�, PURPOSE 1.1 To safely administer chemotherapy drugs to patients for cancer treatment. Parenteral chemotherapy should only be administered by health care professionals who have been specially trained in parenteral chemotherapy administration. NCA Chemotherapy Administration Policy v1.6 2018.03.16 Page 3 of 21 Issue Date 30.03.18 Expiry 30.03.21 1. For Safe Handling of Cytotoxic Medications, refer to . H6�Q��kt�_�ȩ��4�rvП�ڳ��0�fٺ,�:��:&���jT�M��i�w����II�*��״�M�n�KJ��-@. The policy covers administration Pre-treatment checks and potential reasons for not proceeding with treatment are also covered. The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. Teratogenic – able to cause abnormalities in an embryo or fetus that may lead to birth defects. h�b```f``�a`e`��fd@ A����� �00pD0 <> Introduction, Aim and Scope 1.1 This policy aims to provide step by step guidance to support administration and minimise the risks associated with the delivery of Systemic Anti Cancer Therapy (SACT) within the Cancer Alliance. ���$۸I9��r��M"�C�'�9�g�a��8��r%D�n���*WB�m6�Ze�m��1�yܓ*(z��F�10���Wttt0�����(�o��2���$\�3�c`Z��e�X��P~�}�O�'�:H2ni|�\ľ�w�L���O� This Policy outlines the staff who are authorised to administer chemotherapy and other anti-cancer treatments, the areas designated for the administration of anti- cancer treatments and training required. )��m"�[��F�H�Q ���s@lo?�.�#�{��20ݿ��������� �"� Policies & Procedures: Chemotherapy Drugs(Oral) for Cancer and I.D.# 1059 Non-Cancer Treatment: Administration & Precautions Page 2 of 11 Carcinogenic – able to cause the development of cancer. stream In December 2008, ASCO and ONS held a workshop to develop a consensus regarding standards for the safe administration of chemotherapy to adult patients in the outpatient setting. 0 <>/Metadata 1685 0 R/ViewerPreferences 1686 0 R>> 1 0 obj %PDF-1.5 %����